We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Mobile X-Ray Platform Provide Improvements Agility and Flexibility

By HospiMedica International staff writers
Posted on 27 Jul 2011
A new platform of user-friendly, mobile X-ray systems provides improvements in effectiveness, accessibility, and flexibility to help address the increasingly specialized radiographic needs of patients. More...


GE Healthcare (Chalfont St. Giles, UK) announced US Food and Drug Administration (FDA) clearance of Optima XR220amx, Optima XR200amx, and Brivo XR285amx. Building upon GE Healthcare’s innovative medical imaging AMX mobile X-ray product range, these systems are designed to provide healthcare professionals with fast, low-dose, high quality images that can aid in accurate diagnoses as early as possible in challenging clinical settings.

“This new mobile platform represents yet another step toward more patient-centered, user-friendly medical imaging” said Anne LeGrand, vice president and general manager for GE Healthcare’s X-ray business. “In listening to our customers across the globe, we believe a one-size-fits-all approach to X-ray no longer fully satisfies users or best serves patients. These next generation systems are designed to offer new levels of agility, reliability, and access--all in an effort to improve quality of care by bringing X-ray directly to the patient.”

The digital Optima XR220amx, digital-ready Optima XR200amx, and Brivo XR285amx are more compact and powerful than their predecessors. They feature intuitive touch screens, immediate start-up capability, more storage, and the high image quality required in the current radiographic environment.

Mobile X-ray is designed for use when it is not safe or practical to move a patient from his or her bed to the radiology department. Specifically, Optima XR220amx is built to bring digital X-ray directly to the patient in the emergency room, intensive care unit and other clinical settings, while offering ergonomic improvements that can streamline transportation and patient positioning. Optima XR220amx also immediately integrates with GE’s novel FlashPad digital wireless detector.

Integrating FlashPad--a durable and adaptable wireless digital detector--with GE’s new mobile X-ray platform can impact diagnostic confidence while maintaining high image quality at low-dose levels. FlashPad also operates on a dedicated frequency spectrum using sophisticated ultra-wideband technology, thereby avoiding the congestion and competition found on many busy hospital wi-fi networks.

Related Links:

GE Healthcare




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Medical-Grade Display
HL2316SHTB
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.